evoke trial semaglutide Novo Nordisk says semaglutide, the drug used in Wegovy and Ozempic, does not slow Alzheimer's progression, despite early real-world signals that prompted two major trials involving more than 3,800 participants aged semaglutide medscape | Topline results

BPC-157 may be used both as a therapeutic peptide for stroke and heart attack and as a probative peptide to learn how to enhance recovery after ischemic injury

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were originally developed to treat type 2 diabetes, but are becoming increasingly popular for the treatment of obesity because they are effective at helping people lose weight

When to Stop Discontinuation should be considered if IGF-1 exceeds 400 ng/mL on two consecutive measurements, if the patient develops new symptoms of carpal tunnel syndrome (a known GH excess sequela), or if diabetes control deteriorates with HbA1c rising more than 0.5 points from baseline

[PMID: 21152927] PubMed record related to this compound for laboratory literature review